Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis.

These results indicate that, while risks and benefits are both represented in mobile communications and their associated landing pages, they are not equally prominent and accessible. This has implications for compliance with FDA fair balance regulations.